
{"id":6421,"date":"2022-12-12T11:28:43","date_gmt":"2022-12-12T11:28:43","guid":{"rendered":"https:\/\/www.seaspringconsulting.com\/?p=6421"},"modified":"2023-09-14T07:12:23","modified_gmt":"2023-09-14T07:12:23","slug":"biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth","status":"publish","type":"post","link":"https:\/\/www.seaspringconsulting.com\/ar\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\/","title":{"rendered":"Biotricity files FDA 510(k) for a new form factor of its Biotres Cardiac Monitoring Device to expand its revenue growth"},"content":{"rendered":"<p>Biotricity Inc. (Biotricity) today announced that it made a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a new form factor of its Biotres Cardiac Monitoring Device, a three lead device for ECG and arrhythmia monitoring that is intended for lower risk patients.<\/p>","protected":false},"excerpt":{"rendered":"<p>Biotricity Inc. (Biotricity) today announced that it made a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a new form factor of its Biotres Cardiac Monitoring Device,<a href=\"https:\/\/www.seaspringconsulting.com\/ar\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\/\" class=\"exp-read-more exp-read-more-dots\">&#8230;<\/a><\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2,93],"tags":[],"class_list":["post-6421","post","type-post","status-publish","format-standard","hentry","category-biotricity","category-healthcare"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Biotricity files FDA 510(k) for a new form factor of its Biotres Cardiac Monitoring Device to expand its revenue growth - Seaspring<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.seaspringconsulting.com\/ar\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\/\" \/>\n<meta property=\"og:locale\" content=\"ar_AR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biotricity files FDA 510(k) for a new form factor of its Biotres Cardiac Monitoring Device to expand its revenue growth - Seaspring\" \/>\n<meta property=\"og:description\" content=\"Biotricity Inc. (Biotricity) today announced that it made a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a new form factor of its Biotres Cardiac Monitoring Device,...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.seaspringconsulting.com\/ar\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\/\" \/>\n<meta property=\"og:site_name\" content=\"Seaspring\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-12T11:28:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-14T07:12:23+00:00\" \/>\n<meta name=\"author\" content=\"Lakshmy Venkat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@seaspringwll\" \/>\n<meta name=\"twitter:site\" content=\"@seaspringwll\" \/>\n<meta name=\"twitter:label1\" content=\"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lakshmy Venkat\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631\" \/>\n\t<meta name=\"twitter:data2\" content=\"\u062f\u0642\u064a\u0642\u0629 \u0648\u0627\u062d\u062f\u0629\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\\\/\"},\"author\":{\"name\":\"Lakshmy Venkat\",\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/#\\\/schema\\\/person\\\/32694aa2722e4e7a253a30ddbecacca6\"},\"headline\":\"Biotricity files FDA 510(k) for a new form factor of its Biotres Cardiac Monitoring Device to expand its revenue growth\",\"datePublished\":\"2022-12-12T11:28:43+00:00\",\"dateModified\":\"2023-09-14T07:12:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\\\/\"},\"wordCount\":67,\"publisher\":{\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/#organization\"},\"articleSection\":[\"Biotricity\",\"Healthcare\"],\"inLanguage\":\"ar\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\\\/\",\"url\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\\\/\",\"name\":\"Biotricity files FDA 510(k) for a new form factor of its Biotres Cardiac Monitoring Device to expand its revenue growth - Seaspring\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/#website\"},\"datePublished\":\"2022-12-12T11:28:43+00:00\",\"dateModified\":\"2023-09-14T07:12:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\\\/#breadcrumb\"},\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.seaspringconsulting.com\\\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biotricity files FDA 510(k) for a new form factor of its Biotres Cardiac Monitoring Device to expand its revenue growth\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/#website\",\"url\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/\",\"name\":\"Seaspring\",\"description\":\"Link Forward\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ar\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/#organization\",\"name\":\"Seaspring W.L.L.\",\"url\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/94a121.p3cdn1.secureserver.net\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/SeaSpring-Primary-Logo-Original.png?time=1668334512\",\"contentUrl\":\"https:\\\/\\\/94a121.p3cdn1.secureserver.net\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/SeaSpring-Primary-Logo-Original.png?time=1668334512\",\"width\":1412,\"height\":408,\"caption\":\"Seaspring W.L.L.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/seaspringwll\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/#\\\/schema\\\/person\\\/32694aa2722e4e7a253a30ddbecacca6\",\"name\":\"Lakshmy Venkat\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2d55d087e384d86a962ec0d11cc0fc2eaaf711124d600365c924e77da2a6a50f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2d55d087e384d86a962ec0d11cc0fc2eaaf711124d600365c924e77da2a6a50f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2d55d087e384d86a962ec0d11cc0fc2eaaf711124d600365c924e77da2a6a50f?s=96&d=mm&r=g\",\"caption\":\"Lakshmy Venkat\"},\"url\":\"https:\\\/\\\/www.seaspringconsulting.com\\\/ar\\\/author\\\/lakshmy\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biotricity files FDA 510(k) for a new form factor of its Biotres Cardiac Monitoring Device to expand its revenue growth - Seaspring","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.seaspringconsulting.com\/ar\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\/","og_locale":"ar_AR","og_type":"article","og_title":"Biotricity files FDA 510(k) for a new form factor of its Biotres Cardiac Monitoring Device to expand its revenue growth - Seaspring","og_description":"Biotricity Inc. (Biotricity) today announced that it made a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a new form factor of its Biotres Cardiac Monitoring Device,...","og_url":"https:\/\/www.seaspringconsulting.com\/ar\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\/","og_site_name":"Seaspring","article_published_time":"2022-12-12T11:28:43+00:00","article_modified_time":"2023-09-14T07:12:23+00:00","author":"Lakshmy Venkat","twitter_card":"summary_large_image","twitter_creator":"@seaspringwll","twitter_site":"@seaspringwll","twitter_misc":{"\u0643\u064f\u062a\u0628 \u0628\u0648\u0627\u0633\u0637\u0629":"Lakshmy Venkat","\u0648\u0642\u062a \u0627\u0644\u0642\u0631\u0627\u0621\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u0651\u0631":"\u062f\u0642\u064a\u0642\u0629 \u0648\u0627\u062d\u062f\u0629"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.seaspringconsulting.com\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\/#article","isPartOf":{"@id":"https:\/\/www.seaspringconsulting.com\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\/"},"author":{"name":"Lakshmy Venkat","@id":"https:\/\/www.seaspringconsulting.com\/#\/schema\/person\/32694aa2722e4e7a253a30ddbecacca6"},"headline":"Biotricity files FDA 510(k) for a new form factor of its Biotres Cardiac Monitoring Device to expand its revenue growth","datePublished":"2022-12-12T11:28:43+00:00","dateModified":"2023-09-14T07:12:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.seaspringconsulting.com\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\/"},"wordCount":67,"publisher":{"@id":"https:\/\/www.seaspringconsulting.com\/#organization"},"articleSection":["Biotricity","Healthcare"],"inLanguage":"ar"},{"@type":"WebPage","@id":"https:\/\/www.seaspringconsulting.com\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\/","url":"https:\/\/www.seaspringconsulting.com\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\/","name":"Biotricity files FDA 510(k) for a new form factor of its Biotres Cardiac Monitoring Device to expand its revenue growth - Seaspring","isPartOf":{"@id":"https:\/\/www.seaspringconsulting.com\/#website"},"datePublished":"2022-12-12T11:28:43+00:00","dateModified":"2023-09-14T07:12:23+00:00","breadcrumb":{"@id":"https:\/\/www.seaspringconsulting.com\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\/#breadcrumb"},"inLanguage":"ar","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.seaspringconsulting.com\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.seaspringconsulting.com\/biotricity-files-fda-510k-for-a-new-form-factor-of-its-biotres-cardiac-monitoring-device-to-expand-its-revenue-growth\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.seaspringconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Biotricity files FDA 510(k) for a new form factor of its Biotres Cardiac Monitoring Device to expand its revenue growth"}]},{"@type":"WebSite","@id":"https:\/\/www.seaspringconsulting.com\/#website","url":"https:\/\/www.seaspringconsulting.com\/","name":"Seaspring","description":"Link Forward","publisher":{"@id":"https:\/\/www.seaspringconsulting.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.seaspringconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ar"},{"@type":"Organization","@id":"https:\/\/www.seaspringconsulting.com\/#organization","name":"\u0634\u0631\u0643\u0629 \u0633\u064a\u0633\u0628\u0631\u064a\u0646\u063a \u0630.\u0645.\u0645.","url":"https:\/\/www.seaspringconsulting.com\/","logo":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/www.seaspringconsulting.com\/#\/schema\/logo\/image\/","url":"https:\/\/94a121.p3cdn1.secureserver.net\/wp-content\/uploads\/2022\/10\/SeaSpring-Primary-Logo-Original.png?time=1668334512","contentUrl":"https:\/\/94a121.p3cdn1.secureserver.net\/wp-content\/uploads\/2022\/10\/SeaSpring-Primary-Logo-Original.png?time=1668334512","width":1412,"height":408,"caption":"Seaspring W.L.L."},"image":{"@id":"https:\/\/www.seaspringconsulting.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/seaspringwll"]},{"@type":"Person","@id":"https:\/\/www.seaspringconsulting.com\/#\/schema\/person\/32694aa2722e4e7a253a30ddbecacca6","name":"Lakshmy Venkat","image":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/secure.gravatar.com\/avatar\/2d55d087e384d86a962ec0d11cc0fc2eaaf711124d600365c924e77da2a6a50f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2d55d087e384d86a962ec0d11cc0fc2eaaf711124d600365c924e77da2a6a50f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2d55d087e384d86a962ec0d11cc0fc2eaaf711124d600365c924e77da2a6a50f?s=96&d=mm&r=g","caption":"Lakshmy Venkat"},"url":"https:\/\/www.seaspringconsulting.com\/ar\/author\/lakshmy\/"}]}},"_links":{"self":[{"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/posts\/6421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/comments?post=6421"}],"version-history":[{"count":2,"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/posts\/6421\/revisions"}],"predecessor-version":[{"id":6981,"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/posts\/6421\/revisions\/6981"}],"wp:attachment":[{"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/media?parent=6421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/categories?post=6421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.seaspringconsulting.com\/ar\/wp-json\/wp\/v2\/tags?post=6421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}